MedTrace Logo

Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study

NCT07340593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1251

Last updated 2026-01-14

No results posted yet for this study

Summary

This study aims to determine the regional prevalence of Helicobacter pylori infection, bacterial strain differences, and the prevalence of gastric cancer in two provinces of Laos, a multi-ethnic country where these factors may vary by region and ethnicity. The study also evaluates whether H. pylori eradication therapy contributes to disease prevention. Residents aged 18 years or older in Luang Prabang Province and Champasak Province underwent stool antigen testing, and H. pylori-positive individuals received eradication therapy. High-risk participants aged ≥40 years underwent upper gastrointestinal endoscopy for early detection of gastric cancer.

Conditions

  • Gastric Cancer Screening
  • Prevention and Control
  • Helicobacter Eradication
  • Helicobacter Infections

Sponsors & Collaborators

  • Oita University

    collaborator OTHER

  • Setthathirath Hospital

    collaborator OTHER

  • Mahosot Hospital, Laos

    collaborator UNKNOWN

  • Lao National Cancer Center

    collaborator OTHER

  • Zero Helicobacter IGAN Network

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-18
Primary Completion
2024-10-10
Completion
2025-06-07

Countries

  • Laos

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07340593 on ClinicalTrials.gov